NCT06728098View on ClinicalTrials.gov

Safety and Tolerability Evaluation of Akkermansia Muciniphila

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 25, 2025

Primary Completion Date

December 25, 2025

Study Completion Date

March 25, 2026

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Probiotic

The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).

DIETARY_SUPPLEMENT

Maltodextrin

The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).

Trial Locations (1)

10430

RECRUITING

Fakultas Kedokteran Universitas Indonesia, Jakarta Pusat

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY